Patients with type 1 diabetes mellitus (T1DM) showed significantly higher serum levels of CML and high-sensitivity C-reactive protein (CRP) than the control group via an increase in Toll-like receptor 4 (TLR-4) expression in monocytes [13]. This evidence concerns the gene TLR4 and chronic myelogenous leukemia, BCR-ABL1 positive.